Cargando…
Refractory IgG4-related intracranial hypertrophic pachymeningitis responded to rituximab
Autores principales: | Liao, Bing, Kamiya-Matsuoka, Carlos, Fang, Xiang, Smith, Robert G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215390/ https://www.ncbi.nlm.nih.gov/pubmed/25364775 http://dx.doi.org/10.1212/NXI.0000000000000041 |
Ejemplares similares
-
The severe side of the IgG4-related hypertrophic pachymeningitis disease spectrum
por: Schubert, Ryan D., et al.
Publicado: (2016) -
IgG4-related hypertrophic pachymeningitis coexpressing antineutrophil cytoplasmic antibodies
por: Massey, Jennifer
Publicado: (2017) -
IgG4-Related Disease and Hypertrophic Pachymeningitis
por: Wallace, Zachary S., et al.
Publicado: (2013) -
Successful treatment of IgG4‐related hypertrophic pachymeningitis with induction rituximab and dexamethasone followed by maintenance rituximab
por: Seegobin, Karan, et al.
Publicado: (2021) -
IgG4-related hypertrophic pachymeningitis with tumor-like intracranial and intracerebral lesions
por: Esmaeilzadeh, Majid, et al.
Publicado: (2022)